Japan, Aug. 31 -- SANOFI BIOTECHNOLOGY has got intellectual property rights for 'HUMANIZED ANTI-IL-1R3 ANTIBODIES.' Other related details are as follows:
Application Number: JP,2024-069425
Category (FI): A61K39/395@D,A61K39/395@N,A61P43/00,121,A61K45/00,C07K16/28,A61P35/00,C12N15/13
Stage: Grant (IP right granted following substantive examination.)
Filing Date: April 23, 2024
Publication Date: July 30, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
